Cancer of the ovary, fallopian tube, and peritoneum

被引：86
作者：
Berek, Jonathan S. [1 ]
Crum, Christopher [2 ]
Friedlander, Michael [3 ]
机构：
[1] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford Womens Canc Ctr, Stanford, CA 94305 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA
[3] Royal Hosp Women, Sydney, NSW, Australia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS | 2012年 / 119卷
关键词：
GERM-CELL TUMORS; PHASE-III TRIAL; RECURRENT EPITHELIAL OVARIAN; GYNECOLOGIC-ONCOLOGY-GROUP; SECONDARY CYTOREDUCTIVE SURGERY; PACLITAXEL-BASED CHEMOTHERAPY; TERM-FOLLOW-UP; STAGE-III; INTRAPERITONEAL CISPLATIN; INTRAEPITHELIAL CARCINOMA;
D O I：
10.1016/S0020-7292(12)60025-3
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：S118 / S129
页数：12
相关论文
共 107 条
[1]   Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 39 randomized trials [J].
Aabo, K ;
Adams, M ;
Adnitt, P ;
Alberts, DS ;
Athanazziou, A ;
Barley, V ;
Bell, DR ;
Bianchi, U ;
Bolis, G ;
Brady, MF ;
Brodovsky, HS ;
Bruckner, H ;
Buyse, M ;
Canetta, R ;
Chylak, V ;
Cohen, CJ ;
Colombo, N ;
Conte, PF ;
Crowther, D ;
Edmonson, JH ;
Gennatas, C ;
Gilbey, E ;
Gore, M ;
Guthrie, D ;
Kaye, SB ;
Laing, AH ;
Landoni, F ;
Leonard, RC ;
Lewis, C ;
Liu, PY ;
Mangioni, C ;
Marsoni, S ;
Meerpohl, H ;
Omura, GA ;
Parmar, MKB ;
Pater, J ;
Pecorelli, S ;
Presti, M ;
Sauerbrei, W ;
Skarlos, DV ;
Smalley, RV ;
Solomon, HJ ;
Stewart, LA ;
Sturgeon, JFG ;
Tattersall, MHN ;
Wharton, JT ;
Huinink, WWT ;
Tomirotti, M ;
Torri, W ;
Trope, C .
BRITISH JOURNAL OF CANCER, 1998, 78 (11) :1479-1487
[2]   OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [J].
Aghajanian, Carol ;
Blank, Stephanie V. ;
Goff, Barbara A. ;
Judson, Patricia L. ;
Teneriello, Michael G. ;
Husain, Amreen ;
Sovak, Mika A. ;
Yi, Jing ;
Nycum, Lawrence R. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (17) :2039-2045
[3]   Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer [J].
Alberts, DS ;
Liu, PY ;
Hannigan, EV ;
OToole, R ;
Williams, SD ;
Young, JA ;
Franklin, EW ;
ClarkePearson, DL ;
Malviya, VK ;
DuBeshter, B ;
Adelson, MD ;
Hoskins, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) :1950-1955
[4]   Intraperitoneal cisplatin and paclitaxel in ovarian cancer [J].
Armstrong, DK ;
Bundy, B ;
Wenzel, L ;
Huang, HQ ;
Baergen, R ;
Lele, S ;
Copeland, LJ ;
Walker, JL ;
Burger, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :34-43
[5]   Defining the Cut Point Between Low-grade and High-grade Ovarian Serous Carcinomas A Clinicopathologic and Molecular Genetic Analysis [J].
Ayhan, Ayse ;
Kurman, Robert J. ;
Yemelyanova, Anna ;
Vang, Russell ;
Logani, Sanjay ;
Seidman, Jeffrey D. ;
Shih, Ie-Ming .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (08) :1220-1224
[6]   A genetic epidemiological study of carcinoma of the fallopian tube [J].
Aziz, S ;
Kuperstein, G ;
Rosen, B ;
Cole, D ;
Nedelcu, R ;
McLaughlin, J ;
Narod, SA .
GYNECOLOGIC ONCOLOGY, 2001, 80 (03) :341-345
[7]  
Baekelandt M, 2000, CANCER-AM CANCER SOC, V89, P2076
[8]   Symptoms associated with diagnosis of ovarian cancer: a systematic review [J].
Bankhead, CR ;
Kehoe, ST ;
Austoker, J .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2005, 112 (07) :857-865
[9]   Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group study [J].
Bell, Jeffrey ;
Brady, Mark F. ;
Young, Robert C. ;
Lage, Janice ;
Walker, Joan L. ;
Look, Katherine Y. ;
Rose, G. Scott ;
Spirtos, Nick M. .
GYNECOLOGIC ONCOLOGY, 2006, 102 (03) :432-439
[10]   Lymph Node-Positive Stage IIIC Ovarian Cancer A Separate Entity? [J].
Berek, Jonathan S. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 :S18-S20
12345678910